More recently, a cellular thermal shift assay (CETSA) methodology has demonstrated that CAP also binds directly to tNOX and leads to its degradation by the ubiquitin–proteasome and autophagy–lysosome pathways in bladder cancer in vitro (T24 cells) [88,96]. The gene discussed is ENOX2; the disease is urinary bladder cancer.